AllianceBernstein
IPCI

AllianceBernstein’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

AllianceBernstein’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-83
Closed -$4K – 3740
2014
Q1 		$4K Hold
83
– – ﹤0.01% 3357
2013
Q4 		$3K Hold
83
– – ﹤0.01% 3201
2013
Q3 		$2K Buy
+83
New +$1.63K ﹤0.01% 3296

Other funds holding IPCI

TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
FMBTD
First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

AllianceBernstein's IPCI Position: Q2 2014 in Review

AllianceBernstein sold out of Intellipharmaceuticals International Inc. (IPCI) in Q2 2014, closing a stake of 83 shares — an estimated $4K sold.

AllianceBernstein first reported a position in IPCI in Q3 2013 and held it in 3 quarters. The position peaked at $4K in Q1 2014. 19 funds tracked by Wall St. Rank hold IPCI as of Q2 2014.

  • AllianceBernstein reported no remaining Intellipharmaceuticals International Inc. position as of Q2 2014 after selling out during the quarter.
  • AllianceBernstein sold 83 Intellipharmaceuticals International Inc. shares in Q2 2014, an estimated $4K.
  • AllianceBernstein first reported a position in Intellipharmaceuticals International Inc. in Q3 2013 and held it in 3 quarters.
  • AllianceBernstein's Intellipharmaceuticals International Inc. position peaked at $4K in Q1 2014.
  • 19 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q2 2014.

Based on AllianceBernstein's 13F filing for Q2 2014, filed 13 Aug 2014.